Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension
Abstract Pulmonary arterial hypertension (PAH) is a progressive and rare disease without obvious clinical symptoms that shares characteristics with pulmonary vascular remodeling. Right heart failure in the terminal phase of PAH seriously threatens the lives of patients. This review attempts to compr...
Saved in:
Main Authors: | Zhijie Yu (Author), Jun Xiao (Author), Xiao Chen (Author), Yi Ruan (Author), Yang Chen (Author), Xiaoyuan Zheng (Author), Qiang Wang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition
by: Xing Chen, et al.
Published: (2022) -
Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
by: Yong-Jie Chen, et al.
Published: (2021) -
Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
by: Ran-ran Wang, et al.
Published: (2022) -
Natural Medicines for the Treatment of Epilepsy: Bioactive Components, Pharmacology and Mechanism
by: Li-Ying He, et al.
Published: (2021) -
Chinese medicinal plants for the potential management of high-altitude pulmonary oedema and pulmonary hypertension
by: Tingting Wang, et al.
Published: (2020)